Table 2.
Components of human whole blood and PRPs
| Platelet concentration (109/L) | Leukocyte concentration (109/L) | PDGF-AB concentration (ng/mL) | TGF-β1 concentration (ng/mL) | VEGF concentration (pg/mL) | IL-1β concentration (pg/mL) | TNF-α concentration (pg/mL) | |
|---|---|---|---|---|---|---|---|
| WB | 228.30 ± 50.50 | 6.18 ± 1.57 | 8.87 ± 4.67 | 23.83 ± 12.07 | 35.92 ± 8.51 | 11.68 ± 5.90 | 9.31 ± 5.05 |
| L-PRP | 1436.70 ± 257.97 | 34.58 ± 8.48 | 42.54 ± 12.65 | 122.22 ± 43.42 | 157.89 ± 33.64 | 93.33 ± 69.88 | 54.67 ± 27.10 |
| P-PRP | 1461.80 ± 189.14 | 0.18 ± 0.18 | 43.71 ± 14.39 | 126.95 ± 35.96 | 151.82 ± 29.29 | 3.83 ± 2.61 | 2.20 ± 0.78 |
| Comparison, P value | |||||||
| ANOVA | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* |
| WB vs. L-PRP | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* | <0.001* |
| WB vs. P-PRP | <0.001* | 0.036* | <0.001* | <0.001* | <0.001* | >0.999 | 0.979 |
| L-PRP vs. P-PRP | >0.999 | <0.001* | >0.999 | >0.999 | >0.999 | <0.001* | <0.001* |
The asterisks indicate the significant differences between groups on ANOVA and with use of the Bonferroni post hoc test for multiple comparisons (P < 0.05)
WB whole blood